Krämer S - Search Results

1

Selective activation of human intestinal mast cells by Escherichia coli hemolysin.

Krämer S, Sellge G, Lorentz A, Krueger D, Schemann M, Feilhauer K, Gunzer F, Bischoff SC. Krämer S, et al. J Immunol. 2008 Jul 15;181(2):1438-45. doi: 10.4049/jimmunol.181.2.1438. J Immunol. 2008. PMID: 18606698

2

Human mast cells, bacteria, and intestinal immunity.

Bischoff SC, Krämer S. Bischoff SC, et al. Among authors: kramer s. Immunol Rev. 2007 Jun;217:329-37. doi: 10.1111/j.1600-065X.2007.00523.x. Immunol Rev. 2007. PMID: 17498069 Review.

3

Central role of IL-6 and MMP-1 for cross talk between human intestinal mast cells and human intestinal fibroblasts.

Montier Y, Lorentz A, Krämer S, Sellge G, Schock M, Bauer M, Schuppan D, Bischoff SC. Montier Y, et al. Among authors: kramer s. Immunobiology. 2012 Sep;217(9):912-9. doi: 10.1016/j.imbio.2012.01.003. Epub 2012 Jan 4. Immunobiology. 2012. PMID: 22356938 Free article.

4

Interferon-γ regulates growth and controls Fcγ receptor expression and activation in human intestinal mast cells.

Sellge G, Barkowsky M, Kramer S, Gebhardt T, Sander LE, Lorentz A, Bischoff SC. Sellge G, et al. Among authors: kramer s. BMC Immunol. 2014 Jul 5;15:27. doi: 10.1186/1471-2172-15-27. BMC Immunol. 2014. PMID: 24996251 Free PMC article.

5

[Hyponatremia with clinical relevance].

Krämer S, Bischoff SC. Krämer S, et al. Dtsch Med Wochenschr. 2006 Feb 17;131(7):348. doi: 10.1055/s-2006-932524. Dtsch Med Wochenschr. 2006. PMID: 16468107 German. No abstract available.

6

[Therapeutic possibilities of probiotics in antibiotic-related diarrhea].

Krämer S, Bischoff SC. Krämer S, et al. MMW Fortschr Med. 2006 Aug 31;148(35-36):28-30. doi: 10.1007/BF03364716. MMW Fortschr Med. 2006. PMID: 16995359 Review. German.

7

Antibiotics protect against fructose-induced hepatic lipid accumulation in mice: role of endotoxin.

Bergheim I, Weber S, Vos M, Krämer S, Volynets V, Kaserouni S, McClain CJ, Bischoff SC. Bergheim I, et al. Among authors: kramer s. J Hepatol. 2008 Jun;48(6):983-92. doi: 10.1016/j.jhep.2008.01.035. Epub 2008 Mar 14. J Hepatol. 2008. PMID: 18395289

8

Effect of oral lactulose on clinical and immunohistochemical parameters in patients with inflammatory bowel disease: a pilot study.

Hafer A, Krämer S, Duncker S, Krüger M, Manns MP, Bischoff SC. Hafer A, et al. Among authors: kramer s. BMC Gastroenterol. 2007 Sep 4;7:36. doi: 10.1186/1471-230X-7-36. BMC Gastroenterol. 2007. PMID: 17784949 Free PMC article. Clinical Trial.

9

Remission induction therapies and long-term outcomes in granulomatosis with polyangiitis and microscopic polyangiitis: real-world data from a European cohort.

Krämer S, Vogt K, Schreibing TM, Busch M, Schmitt T, Bergner R, Mosberger S, Neumann T, Rauen T. Krämer S, et al. Rheumatol Int. 2024 Dec 24;45(1):7. doi: 10.1007/s00296-024-05757-4. Rheumatol Int. 2024. PMID: 39718586 Free PMC article.

10

TAM receptors mediate the Fpr2-driven pain resolution and fibrinolysis after nerve injury.

Hartmannsberger B, Ben-Kraiem A, Kramer S, Guidolin C, Kazerani I, Doppler K, Thomas D, Gurke R, Sisignano M, Kalelkar PP, García AJ, Monje PV, Sammeth M, Nusrat A, Brack A, Krug SM, Sommer C, Rittner HL. Hartmannsberger B, et al. Among authors: kramer s. Acta Neuropathol. 2024 Dec 16;149(1):1. doi: 10.1007/s00401-024-02840-9. Acta Neuropathol. 2024. PMID: 39680199 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,085 results

Search Page

Filters